Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
151-165 of 2214 results
Shire acquires Dyax for $5.9bn
Irish-headquartered Shire has acquired the US-based biopharmaceutical firm Dyax for about $5.9bn.
Production & Manufacturing > Manufacturing > News
Asterias transfers AST-VAC2 manufacturing process to Cancer Research UK
Asterias Biotherapeutics has completed the transfer of its manufacturing processes to produce AST-VAC2 to Cancer Research UK.
Production & Manufacturing > Manufacturing > News
Drug companies urge governments to join fight on superbugs
By PBR Staff Writer
Drug manufacturers from across the world called for governments and industry to join forces in combating superbugs, which are strains of bacteria that are resistant to various antibiotic types.
Production & Manufacturing > Manufacturing > News
Cellectis inks deal with CELLforCURE for cGMP manufacturing of UCART123
Cellectis has signed agreement with CELLforCURE for the cGMP manufacturing of UCART123 clinical batches for hematological malignancies.
Production & Manufacturing > Manufacturing > News
GlobalData says Shire's acquisition of Baxalta marks strong start to healthcare mergers and acquisitions for 2016
With Shire's acquisition of Baxalta International expected to generate sales of $20bn by 2020, the deal marks a strong start to healthcare Mergers and Acquisitions (M&A) for 2016, following on from a record-breaking year in which global transactions totaled $680bn in 2015, according to research and consulting firm GlobalData.
Production & Manufacturing > Manufacturing > News
Oxford BioMedica wins UK MHRA approval to manufacture bulk drug material at Yarnton plant
Oxford BioMedica has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture bulk drug material for Investigational Medicinal Products (IMPs) at the Group’s recently established and commissioned specialist biomanufacturing facility in Yarnton, Oxford, UK.
Production & Manufacturing > Manufacturing > News
Shire and Baxalta agree on $32bn merger
By PBR Staff Writer
Irish drugmaker Shire has agreed to merge with American biopharmaceutical firm Baxalta under a transaction worth about $32bn.
Production & Manufacturing > Manufacturing > News
Agenus acquires PhosImmune with novel class of cancer neoantigens
Agenus has acquired PhosImmune, a company that has discovered an entirely new portfolio of cancer neoantigens.
Production & Manufacturing > Manufacturing > News
Seattle Genetics and Bristol-Myers Squibb start new trial assessing combination of Adcetris and Opdivo
By PBR Staff Writer
US-based Seattle Genetics and Bristol-Myers Squibb have initiated a new trial assessing Adcetris (brentuximab vedotin) in combination with Opdivo (nivolumab).
Production & Manufacturing > Manufacturing > News
Samsung breaks ground on third biopharmaceutical manufacturing plant in South Korea
By PBR Staff Writer
Samsung BioLogics has broken ground on its third biopharmaceutical manufacturing plant in Incheon Free Economic Zone, Songdo, South Korea.
Production & Manufacturing > Manufacturing > News
AAIPharma Services/Cambridge Major Laboratories upgrade small molecule manufacturing capabilities at Weert site
AAIPharma Services Corp. / Cambridge Major Laboratories has upgraded its small molecule manufacturing capabilities at its site in Weert, Netherlands with the installation of a DE Dietrich Agitated Filter Dryer for controlled isolation of Intermediates and Active Pharmaceutical Ingredients (APIs).
Production & Manufacturing > Manufacturing > News
AstraZeneca to buy 55% stake in Acerta Pharma for $4bn
By PBR Staff Writer
AstraZeneca has agreed to acquire a 55% stake in privately-owned biotech firm Acerta Pharma for $4bn.
Production & Manufacturing > Manufacturing > News
AstraZeneca strengthens Chinese operations and respiratory business with new deals
By PBR Staff Writer
AstraZeneca has announced two new agreements, one to develop next-generation biologics in China, and the other to expand its respiratory franchise.
Production & Manufacturing > Manufacturing > News
Sanofi, Boehringer Ingelheim in negotiations for asset swap
By PBR Staff Writer
Sanofi and Boehringer Ingelheim are in exclusive talks on a potential asset swap that would see the French pharmaceutical firm swap its animal health unit (Merial) with the German company's consumer healthcare (CHC) business.
Production & Manufacturing > Manufacturing > News
AstraZeneca considering Acerta Pharma bid to acquire blood cancer drug
By PBR Staff Writer
AstraZeneca is in negotiations with cancer drug maker Acerta Pharma on a potential deal to strengthen its cancer drug portfolio.
Production & Manufacturing > Manufacturing > News
151-165 of 2214 results